Search

AmCURE Antibiotic

About

Targeted antimicrobial treatment for resistant infections

Antimicrobial resistance (AMR) poses a grave risk, potentially ushering in a “post-antibiotic era” where even minor infections could become deadly. Traditional antibiotics are losing efficacy, and new alternatives, like cationic polymers, show promise but face issues with in vivo toxicity. AmCURE addresses this by employing a “caging” strategy, where antimicrobials are deactivated and safely contained until reaching the infection site. This method releases the antimicrobials only in the presence of specific bacterial enzymes, reducing toxicity and enhancing treatment efficacy

Student

  • Bo Zhang

    Bo Zhang

    Bo Zhang is a final-year Ph.D. candidate in Chemical and Biomedical Engineering at Nanyang Technological University, Singapore. He received his B.Sc. in Pharmaceutical Sciences in 2021 from Peking University, China, after which he came to NTU to pursue a doctoral degree with a research focus on novel antimicrobials to combat the emerging global antibiotic resistance crisis. Bo also has experience developing commercialization plans for the medical diagnostic technology developed by his lab and has interned for a biopharmaceutical private equity firm. Upon completion of Ph.D., he intends to dedicate himself to the commercialization and clinical translation of innovative medicine. more

Discover
the
Project


Similiar Projects

AiSee

AiSee

Wearable technology

National University of Singapore

AI-powered wearable device for real-time visual assistance

ANGIE

ANGIE

Patient comfort

ETH Zurich

Magnetically guided microcapsules for brain tumour treatment

Belly Buddy

Belly Buddy

Health and Well-being

Harvard University

Early detection and non-invasive correction of breech pregnancies

Chemo Descell

Chemo Descell

Breast cancer

Decellularized ECM model for breast cancer studies